Saturday, May 11 2024
10:15 AM – 10:30 AM ET - Room 307-308
394: Ten-Year Durability of AAV8-MTM1 Gene Transfer in a Canine Model of X-Linked Myotubular Myopathy
David Mack - PhD
University of Washington
Disclosures: D.L. Mack: 1; Commercial Interest i.e. Company X; Kinea Bio, Inc. 1; What was received? i.e. Honorarium; stock. 1; For what role? i.e. Speaker; Founder. 2; Commercial Interest i.e. Company X; Curi Bio, Inc. 2; What was received? i.e. Honorarium; N/A. 2; For what role? i.e. Speaker; Member SAB. 3; Commercial Interest i.e. Company X; Vita Therapeutics, Inc.. 3; What was received? i.e. Honorarium; N/A. 3; For what role? i.e. Speaker; Member SAB. 4; Commercial Interest i.e. Company X; Astellas Gene Therapies. 4; What was received? i.e. Honorarium; Sponsored research agreement. 4; For what role? i.e. Speaker; Consultancy, R&D. 5; Commercial Interest i.e. Company X; Kate Therapeutics, Inc.. 5; What was received? i.e. Honorarium; Sponsored research agreement. 5; For what role? i.e. Speaker; R&D.
Related Abstract